Evaluating a Treatment Effect in Patients With FBSS Using an Electronic Nose: a Pilot Study
NOSE
1 other identifier
interventional
27
1 country
1
Brief Summary
This study is an experimental single-center pilot study investigating Volatile Organic Compounds patterns in exhaled breath during on and off states of SCS, in patient with Failed Back Surgery Syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2020
CompletedFirst Posted
Study publicly available on registry
July 14, 2020
CompletedStudy Start
First participant enrolled
December 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2021
CompletedMay 21, 2021
May 1, 2021
4 months
July 9, 2020
May 20, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Exhaled breath changes
The investigators will examine the difference in exhaled breath patterns between both measurements (SCS on versus SCS off), measured with the Aeonose.
Two times on the same day; once while SCS is switched off and once while SCS is switched on. Total study duration lasts one day.
Secondary Outcomes (1)
Pain intensity scores using the Visual Analogue Scale
Two times on the same day; once while SCS is switched off and once while SCS is switched on. Total study duration lasts one day.
Study Arms (2)
SCS off
EXPERIMENTALSCS on
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Diagnosis of FBSS (Failed conservative treatments for pain including but not limited to pharmacological therapy and physical therapy) and currently being treated with spinal cord stimulation.
You may not qualify if:
- Patients with a diagnosis of cancer.
- Patients with major psychiatric problems.
- Patients with an underlying respiratory disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitair Ziekenhuis Brussellead
- the eNose companycollaborator
Study Sites (1)
Universitair Ziekenhuis Brussel
Jette, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maarten Moens, Prof. dr.
Universitair Ziekenhuis Brussel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
July 9, 2020
First Posted
July 14, 2020
Study Start
December 12, 2020
Primary Completion
March 27, 2021
Study Completion
March 27, 2021
Last Updated
May 21, 2021
Record last verified: 2021-05